Open AccessRosiglitazone alleviates lipopolysaccharide‑induced inflammation in RAW264.7 cells via inhibition of NF‑κB and in a PPARγ‑dependent manner
Author(s) -
Jingping Zhou,
Xiaoning Yang,
Yang Song,
Fei Zhou,
Jingjing Liu,
Yiqun Hu,
Ligang Chen
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10175
Subject(s) - rosiglitazone , inflammation , molecular medicine , oncogene , nf κb , apoptosis , lipopolysaccharide , nfkb1 , peroxisome proliferator activated receptor , cancer research , cell cycle , tumor necrosis factor alpha , microbiology and biotechnology , medicine , chemistry , receptor , biology , transcription factor , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom